TBX1 Inhibitors
Chemicals classified as TBX1 inhibitors are those that affect TBX1 indirectly by targeting signaling pathways or cellular processes that the TBX1 protein is involved with. Since TBX1 plays a role in the regulation of developmental processes, these inhibitors are primarily investigated within the context of cellular signaling modulation. For instance, the inhibition of key components of the Wnt signaling pathway, such as PORCN with Wnt-C59 or GSK-3β with Chir99021, results in changes in cellular communication and fate that can affect TBX1 activity.
Moreover, the TBX1 protein is also subject to regulation by the TGF-β pathway, the MAPK/ERK pathway, and the PI3K/AKT pathway. Inhibitors like LY294002, PD98059, and SB431542 target enzymes and receptors within these pathways, altering the cascade of events that lead to TBX1's role in cell proliferation, differentiation, and survival. Compounds like Rapamycin and U0126 act further downstream in these signaling pathways to affect TBX1. It is through these complex interactions and regulatory mechanisms that TBX1 function is modulated, with these chemicals serving as indirect modulators of TBX1 activity within the cellular environment.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wnt-C59 | 1243243-89-1 | sc-475634 sc-475634A sc-475634B | 5 mg 10 mg 50 mg | $214.00 $326.00 $1275.00 | 1 | |
Inhibits the palmitoyltransferase PORCN, which is required for Wnt post-translational modifications and secretion, thus indirectly affecting Wnt signaling which can modulate TBX1. | ||||||
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $40.00 $120.00 $480.00 $2141.00 | 47 | |
Inhibits γ-secretase, an enzyme involved in Notch pathway activation; altered Notch signaling can have downstream effects on the expression and function of TBX1. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibits phosphoinositide 3-kinases (PI3K), potentially altering PI3K/AKT pathway activity, which can have downstream effects on TBX1 function. | ||||||
GSK-3 Inhibitor XVI | 252917-06-9 | sc-221691 sc-221691A | 5 mg 25 mg | $180.00 $610.00 | 4 | |
Inhibits GSK-3β, which can lead to the stabilization of β-catenin, a component of the Wnt signaling pathway, indirectly affecting TBX1. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, affecting the JNK signaling pathway, which can indirectly alter TBX1 function as part of the cellular response to stress. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Inhibits Rho-associated protein kinase (ROCK), potentially impacting actin cytoskeleton organization and cell morphology, which can influence TBX1 function. | ||||||